AR078170A1 - Metodos para el tratamiento de tumores cerebrales - Google Patents

Metodos para el tratamiento de tumores cerebrales

Info

Publication number
AR078170A1
AR078170A1 ARP100103326A ARP100103326A AR078170A1 AR 078170 A1 AR078170 A1 AR 078170A1 AR P100103326 A ARP100103326 A AR P100103326A AR P100103326 A ARP100103326 A AR P100103326A AR 078170 A1 AR078170 A1 AR 078170A1
Authority
AR
Argentina
Prior art keywords
meta
sodium
arsenite
treatment
brain tumor
Prior art date
Application number
ARP100103326A
Other languages
English (en)
Inventor
Yong Joon Jo
Yong-Jin Yang
Original Assignee
Kominox Usa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kominox Usa Inc filed Critical Kominox Usa Inc
Publication of AR078170A1 publication Critical patent/AR078170A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Reivindicacion 1: Uso de meta arsenita de sodio, caracterizado porque es en la elaboracion de una composicion farmacéutica para el tratamiento de un tumor cerebral en un paciente humano, en donde dicha meta arsenita de sodio atraviesa la barrera hematoencefálica humana. Reivindicacion 8: Un conjunto de elementos, caracterizado porque comprende una o más unidades de dosificacion de meta arsenita de sodio formulada para una administracion oral o intravenosa y una o más unidades de dosificacion de un agente quimioterapéutico anti-tumor cerebral diferente de la meta arsenita de sodio y formulada para una administracion oral o intravenosa. Reivindicacion 9: El conjunto de elementos de la reivindicacion 8, caracterizado porque el agente quimioterapéutico anti-tumor cerebral se selecciona entre agentes alquilantes, antifolatos y topoisomerasas.
ARP100103326A 2009-09-18 2010-09-10 Metodos para el tratamiento de tumores cerebrales AR078170A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24364809P 2009-09-18 2009-09-18

Publications (1)

Publication Number Publication Date
AR078170A1 true AR078170A1 (es) 2011-10-19

Family

ID=43756836

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP100103326A AR078170A1 (es) 2009-09-18 2010-09-10 Metodos para el tratamiento de tumores cerebrales

Country Status (15)

Country Link
US (1) US20110070314A1 (es)
EP (1) EP2477635A4 (es)
JP (1) JP2013505242A (es)
KR (1) KR20120048706A (es)
CN (1) CN102753188A (es)
AR (1) AR078170A1 (es)
AU (1) AU2010295841A1 (es)
BR (1) BR112012008310A2 (es)
CA (1) CA2772777A1 (es)
IN (1) IN2012DN02195A (es)
MX (1) MX2012002922A (es)
RU (1) RU2012108439A (es)
SG (1) SG179192A1 (es)
TW (1) TW201114431A (es)
WO (1) WO2011034775A2 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201608967WA (en) * 2009-09-10 2016-12-29 Kominox Inc Cancer stem cell-targeted and drug resistant cancer therapy
KR101309036B1 (ko) * 2011-05-30 2013-09-16 주식회사 코미팜 방사선 민감도 증진용 약학 조성물
US8781202B2 (en) * 2012-07-26 2014-07-15 International Business Machines Corporation Tumor classification based on an analysis of a related ultrasonic attenuation map
US10076652B2 (en) * 2015-08-10 2018-09-18 Chang Gung University Method for ultrasound-mediated delivery system to monitor molecular penetration
EP3768247A4 (en) * 2018-03-22 2021-12-29 Komipharm International Australia Pty Ltd Pharmaceutical composition comprising meta arsenite and method of manufacture
KR20220020637A (ko) * 2020-08-12 2022-02-21 이상봉 항암화학요법이나 방사선요법으로 인한 암 환자의 탈모증을 포함한 탈모증 환자에 대하여 탈모를 방지하고 발모를 촉진하는 메타아르세나이트의 염을 함유하는 경구 투여용 약학적 조성물
KR20220020635A (ko) * 2020-08-12 2022-02-21 이상봉 탈모방지 또는 발모촉진용 외용제 조성물
KR20220020633A (ko) * 2020-08-12 2022-02-21 이상봉 탈모방지 또는 발모촉진용 주사제 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69842094D1 (de) * 1997-10-15 2011-02-17 Polarx Biopharmaceuticals Inc Zusammensetzungen und Verfahren zur Behandlung primärer und metastatischer Erkrankungen mithilfe Arsentrioxid
KR20020083678A (ko) * 2001-04-28 2002-11-04 주식회사 한국미생물연구소 아르세닉산나트륨 염, 소디움 메타아르세나이트 또는 이의혼합물을 함유한 항암제 조성물
LT1496918T (lt) * 2002-04-10 2023-05-25 Komipharm International Co., Ltd. Natrio meta-arsenito naudojimas navikams gydyti
WO2006104292A1 (en) * 2005-03-31 2006-10-05 Komipharm International Co., Ltd. Pharmaceutical composition comprising arsenic acid, meta-arsenite, and pharmaceutically acceptable salts
EP1721615A1 (en) * 2005-05-09 2006-11-15 Komipharm International Co., Ltd. Pharmaceutical compositions comprising sodium or potassium arsenite for the treatment of urogenital cancer and its metastasis

Also Published As

Publication number Publication date
EP2477635A2 (en) 2012-07-25
US20110070314A1 (en) 2011-03-24
MX2012002922A (es) 2012-09-07
WO2011034775A3 (en) 2011-10-06
KR20120048706A (ko) 2012-05-15
CN102753188A (zh) 2012-10-24
IN2012DN02195A (es) 2015-08-21
EP2477635A4 (en) 2013-03-27
TW201114431A (en) 2011-05-01
SG179192A1 (en) 2012-05-30
BR112012008310A2 (pt) 2017-06-06
AU2010295841A1 (en) 2012-03-29
WO2011034775A2 (en) 2011-03-24
CA2772777A1 (en) 2011-03-24
JP2013505242A (ja) 2013-02-14
RU2012108439A (ru) 2013-10-27

Similar Documents

Publication Publication Date Title
AR078170A1 (es) Metodos para el tratamiento de tumores cerebrales
RU2757373C2 (ru) Комбинированная терапия противоопухолевым алкалоидом
ES2653615T3 (es) Pluralidad de dosis de LAG-3 recombinante para su uso en la provocación de una respuesta inmunitaria de monocitos
JP2020128432A (ja) がんの処置のための併用治療
CY1119886T1 (el) Μεθοδος βιομηχανικης κατασκευης μιας φαρμακευτικης συνθεσης στην μορφη δισκιων παρατεταμενης απελευθερωσης που περιεχουν πιρφενιδονη και χρηση αυτων στην υποστροφη χρονιας νεφρικης ανεπαρκειας, καψικης συσπασης μαστου και ηπατικης ινωσης σε ανθρωπους
Woyach et al. New therapeutic advances in the management of progressive thyroid cancer
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
MX2019013701A (es) Metodos para mejorar suministro de farmacos y efectividad de agentes terapeuticos.
AR068185A1 (es) Composiciones de tabletas de desintegracion oral de lamotrigina
WO2008131057A3 (en) Sustained release formulations of opioid and nonopioid analgesics
EA201492010A1 (ru) Применение высокой дозы лахинимода для лечения рассеянного склероза
EA200870254A1 (ru) Способ лечения воспалительных заболеваний
MX2015012559A (es) Novedosos fármacos de alta penetración y sus composiciones para el tratamiento de enfermedades de parkinson.
HK1071310A1 (en) Combination therapy for the treatment of cancer
AR089862A1 (es) USO DE LAQUINIMOD PARA EL TRATAMIENTO DE PACIENTES CON ENFERMEDAD DE CROHN EN QUIENES FRACASO UNA TERAPIA ANTI-FACTOR DE NECROSIS TUMORAL a (ANTI-TNFa) DE PRIMERA LINEA
ATE494889T1 (de) Pharmazeutische kombination mit 3- (3- dimethylamino-1-ethyl-2-methyl-propyl)-phenol und paracetamol
RU2010151660A (ru) Способы лечения множественной миеломы
WO2014160216A3 (en) Dual targeting anticancer agents
BR112013010829B8 (pt) Composição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação
JP2006500346A5 (es)
MX2022011372A (es) Composiciones de zinc-y-pga y metodos para tratar el cancer.
AR079000A1 (es) Terapia anticancerosa dirigida a celulas madre cancerosas resistentes a las drogas
JP2014534229A5 (es)
UA115250C2 (uk) Фармацевтичні комбінації
SG10201708886RA (en) α-PGA-ZINC COMPOSITIONS AND METHODS FOR TREATING CANCER

Legal Events

Date Code Title Description
FB Suspension of granting procedure